
The Direxion Daily LLY Bull 2X ETF is engineered to deliver daily investment results that are twice (200%) the performance of Eli Lilly and Company's (LLY) common shares. Conversely, the Direxion Daily LLY Bear 1X ETF endeavors to provide daily returns equal to the inverse (opposite) of LLY's share performance, at a 100% ratio. Both ETFs pursue these objectives before factoring in any fees or operational expenses.
Is ELIL's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

2025 has so far been a big year for leveraged ETFs. I wrote a research note on leveraged ETFs earlier this year (read more here) where I discussed some trends in the leveraged ETF market.

Getting stuck in sideways purgatory can leave traders flummoxed. Should they cut bait or ride out the position in hopes that it will eventually trend upwards?

Wall Street delivered mixed-to-downbeat performance last week thanks to Powell's warning of stagflation, rise of auto stocks on policy hopes, NVIDIA's $5.5B hit on export curb and upbeat retail sales.